Here are relevant reports on : ai-in-drug-discovery-discovery-market
-
Europe Proteomics Market by Instrumentation [Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray], Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery) - Forecast to 2030
The Europe Proteomics market, valued at USD9.80 billion in 2024, stood at USD10.55 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of USD18.77 billion by the end of the period.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Base Editing Market by Product (Platform, Reagents & Kits, Plasmids), Service (gRNA Design, Cell Line Engineering), Type, Targeted base (Cytosine, Adenine), Application (Drug Discovery, Agriculture, Veterinary), and Region - Global Forecast to 2028
The global base editing market, valued at US$260 million in 2022, stood at US$270 million in 2023 and is projected to advance at a resilient CAGR of 15.2% from 2023 to 2028, culminating in a forecasted valuation of US$549 million by the end of the period.The growth of the base editing market is largely driven by the rising prevalence of genetic diseases, and the increasing recognition of the role of genetic mutations in various diseases has fueled the demand for precise gene editing technologies.
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Protein Microarrays Market by Offering (Products, Services), Type (Biochips, Microarray Instruments), Application (Clinical, Drug Discovery) - Global Forecast to 2030
The global protein microarrays market, valued at US$0.93 billion in 2024, stood at US$1.00 billion in 2025 and is projected to advance at a resilient CAGR of 12.3% from 2025 to 2030, culminating in a forecasted valuation of US$1.78 billion by the end of the period.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Europe Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Service, Application (Drug Discovery, Diagnostic, Agriculture)-Forecast to 2030
The Europe Next-generation Sequencing Market, valued at US$4.11 billion in 2024, stood at US$4.42 billion in 2025 and is projected to advance at a resilient CAGR of 15.0% from 2025 to 2030, culminating in a forecasted valuation of US$8.88 billion by the end of the period. The Europe next-generation sequencing market is expanding on the back of accelerating use of sequencing across oncology, rare disease diagnostics, and broader precision medicine programs, supported by robust public and private research funding
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Quantum Computing in Healthcare Market by Component (Hardware, Software), Deployment (On-premises, Cloud-based), Technology (Superconducting Qubits, Trapped Ions), Application (Drug Discovery, Genomics), End User, and Region - Global Forecast to 2030
The global quantum computing in healthcare market, valued at US$191.3 million in 2024, stood at US$265.9 million in 2025 and is projected to advance at a resilient CAGR of 37.9% from 2025 to 2030, culminating in a forecasted valuation of US$1324.2 million by the end of the period. The quantum computing in healthcare market is rapidly growing, driven by the need for faster and more advanced data analysis in areas like drug discovery, genomics, and precision medicine.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Tissue Banking Market by Product (Equipment, Consumables, Media, Accessories), Services (Tissue Retrieval, Processing), Application (Drug Discovery, Therapeutic) - Global Trends & Forecast to 2019
Tissue banks facilitate the collection and banking of freshly-frozen tissue specimens. These tissues play a vital role in research into diseases and disorders, and general healthcare. They can be used to repair damaged heart muscles post-heart attacks, in skin replacement for burn victims, and in the treatment of spinal cord injuries, among other significant applications. The advancement of clinical trials and biomedical research in organ transplantation has created many prospects for tissue preservation and banking.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
High Content Screening Market by Product & Services (Instrument (Cell Imaging, Analysis System), Consumables (Reagents & Assay Kits, Microplates), Software), Application (Drug Discovery & Development, Toxicology), End User - Global Forecast to 2030
Global high content screening market valued at $1.47B in 2024, reached $1.52B in 2025, and is projected to grow at a robust 7.5% CAGR, hitting $2.19B by 2030. Market growth in the Asia Pacific can be attributed to the increased pharmaceutical and biotechnology investments and the rising demand for personalized medicine.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
South Korea Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing (Consumables), Platforms, Bioinformatics), Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2031
The South Korea next-generation sequencing market, valued at USD 0.19 billion in 2025, stood at USD 0.20 billion in 2026 and is projected to advance at a resilient CAGR of 14.0% from 2026 to 2031, culminating in a forecasted valuation of USD 0.39 billion by the end of the period. The report profiles key players such as Illumina Inc. (US), Thermo Fisher Scientific Inc. (US), QIAGEN (Netherlands), PacBio (US), and Oxford Nanopore Technologies plc. (UK).
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Chromatography Resin Market in Drug Discovery by Type (Natural, Synthetic, Inorganic Media), Technique (Ion Exchange, Affinity, Hydrophobic Interaction, Size Exclusion, Multi-Modal), and Region - Global Forecast to 2022
MarketsandMarkets projects that the market for chromatography resin in drug discovery will grow from USD 290.7 Million in 2017 to USD 401.1 Million by 2022, at a CAGR of 6.65% from 2017 to 2022. The growth of this market is expected to be driven by the rising demand from pharmaceuticals and biotechnology verticals. Companies such as General Electric Company (U.S.), Merck KGaA (Germany), Pall Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Tosoh Corporation (Japan) were the key players who adopted these strategies to increase their customer base and widen their product portfolio.
- Published: June 2017
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence in Genomics Market by Offering (Software & Services), Technology (Machine Learning), Functionality (Gene Sequencing, Gene Editing), Application (Diagnostics, Drug discovery), End User (Pharma, Hospitals) - Global Forecast to 2028
The global artificial intelligence in genomics market, valued at US$0.4 billion in 2022, stood at US$0.5 billion in 2024 and is projected to advance at a resilient CAGR of 32.3% from 2024 to 2028, culminating in a forecasted valuation of US$2.0 billion by the end of the period. The growth in this market is predominantly driven by the need to accelerate processes and timelines, reduce costs of drug development and discovery, and improve computing power through declining hardware costs.
- Published: May 2023
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
